Cargando…
Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice
Dendritic cells (DCs) excel at cross-presenting antigens, but their effectiveness as cancer vaccine is limited. Here, we describe a vaccination approach using mesenchymal stromal cells (MSCs) engineered to express the immunoproteasome complex (MSC-IPr). Such modification instills efficient antigen c...
Autores principales: | Abusarah, Jamilah, Khodayarian, Fatemeh, El-Hachem, Nehme, Salame, Natasha, Olivier, Martin, Balood, Mohammad, Roversi, Katiane, Talbot, Sebastien, Bikorimana, Jean-Pierre, Chen, Jingkui, Jolicoeur, Mario, Trudeau, Louis-Eric, Kamyabiazar, Samaneh, Annabi, Borhane, Robert, Francis, Pelletier, Jerry, El-Kadiry, Abed-El-Hakim, Shammaa, Riam, Rafei, Moutih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714858/ https://www.ncbi.nlm.nih.gov/pubmed/35028603 http://dx.doi.org/10.1016/j.xcrm.2021.100455 |
Ejemplares similares
-
Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous Phagocytes
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2022) -
The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2022) -
Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity via Cross-Priming of Endogenous Dendritic Cells
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2021) -
Mesenchymal Stem Cells Beyond Regenerative Medicine
por: Shammaa, Riam, et al.
Publicado: (2020) -
CD146 Defines a Mesenchymal Stromal Cell Subpopulation with Enhanced Suppressive Properties
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2022)